And further methylation analysis demonstrated that the aberrant hypermethylation of the regions around the transcription start site of C5orf66-AS1 was more tumor specific and was associated with its lower expression possibly through abrogating Sp1 binding, which expression level was related to tumor progression, including poorer GCA patients’ survival [75]. The gene discussed is PITX1-AS1; the disease is neoplasm.